DR. STEVEN M GREENBERG MD PHD
Prescription History 1508847310
Psychiatry & Neurology - Neurology in Boston, MA

Active since November 09, 2005PECOS EnrolledAccepts Medicare Assignment
15 PARKMAN ST, WAC 836, BOSTON, MA 02114(617) 724-1874(617) 726-5346 Get Directions

NPPES record last updated: December 13, 2023. Verified against the NPPES registry weekly; last sync: August 09, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. STEVEN M GREENBERG MD PHD, an active Neurology specialist practicing in Boston, MA. Our medical registry currently tracks 3 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 64 documented patient claims. Among these therapy options, the most frequently utilized medication is Minocycline Hcl, which accounts for 30 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

3
Medications
64
Total Claims
103
30-Day Fills
Minocycline Hcl
Most Prescribed · 30 claims
View details
3 medications · 2023 Medicare Part D
Medicare Part D medications prescribed by DR. STEVEN M GREENBERG MD PHD in 2023, with prescription volumes, average cost per fill, and MA state comparisons
Medication Prescriptions (2023)Rx (2023) Avg Cost per FillCost / Fill Vs. Other MA PrescribersVs. MA Avg
Minocycline Hcl30$35.59 More than typical

About Minocycline Hcl: This medication is used to treat acne or rosacea. Show more ▾

Minocycline belongs to a class of drugs known as tetracycline antibiotics. However, it is not used to treat skin infections. It helps decrease pimples and red bumps that happen with acne or rosacea. A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections.

In 2023, this provider wrote 30 Medicare prescriptions for Minocycline Hcl, about 1.4 times the volume of the typical Massachusetts prescriber of this medication (22). Medicare paid an average of $35.59 per fill, versus $34.33 statewide.

How often this provider prescribes it

This provider
30
MA average
22.0

This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$35.59
MA average
$34.33

Gross Part D cost per fill; not the patient's out-of-pocket price.

41
30-Day Fills
standardized to 30-day supplies
1,221
Days of Medication
total across all patients in 2023
Memantine Hcl21$145.90 Less than typical

About Memantine Hcl: Memantine is used to treat moderate to severe confusion (dementia) related to Alzheimer's disease. Show more ▾

It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to perform daily functions. This medication works by blocking the action of a certain natural substance in the brain (glutamate) that is believed to be linked to symptoms of Alzheimer's disease.

In 2023, this provider wrote 21 Medicare prescriptions for Memantine Hcl, about half the volume of the typical Massachusetts prescriber of this medication (44). Medicare paid an average of $145.90 per fill, versus $63.98 statewide.

How often this provider prescribes it

This provider
21
MA average
44.0

This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$145.90
MA average
$63.98

Gross Part D cost per fill; not the patient's out-of-pocket price.

47
30-Day Fills
standardized to 30-day supplies
1,361
Days of Medication
total across all patients in 2023
EliquisApixaban13$703.77▼ below MA avg Less than typical

About Eliquis: Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. Show more ▾

With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood.

In 2023, this provider wrote 13 Medicare prescriptions for Eliquis, about 17% of the volume of the typical Massachusetts prescriber of this medication (77). Medicare paid an average of $703.77 per fill, versus $792.72 statewide.

How often this provider prescribes it

This provider
13
MA average
77.0

This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$703.77
MA average
$792.72

This provider's average cost per fill is below the MA average for this medication.

15
30-Day Fills
standardized to 30-day supplies
450
Days of Medication
total across all patients in 2023
No medications match the current filters.
More than typical Typical Less than typical= prescription volume vs the average MA prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the MA average cost per fill.

About this data. The prescription history for DR. STEVEN M GREENBERG MD PHD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Neurology prescribing approach at this Boston, MA practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among MA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.